
2025-11-13 12:29:16
北京科昕生物科技有限公(gong)司(si)的(de)CNTF產品(pin)成(cheng)分(fen)清(qing)晰,依托嚴格的(de)產品(pin)質(zhi)量(liang)控制體系(xi)明確(que)成(cheng)分(fen)構(gou)成(cheng),符合GMP要求。CNTF(睫狀神(shen)經營(ying)養因子,Ciliary Neurotrophic Factor)是一種神(shen)經營(ying)養因子,結(jie)構(gou)與IL-6、LIF等相(xiang)似,具有四螺旋(xuan)束的(de)典(dian)型結(jie)構(gou)。CNTF能促進多種神(shen)經元(yuan)的(de)存活,如交感神(shen)經元(yuan)、感覺神(shen)經元(yuan)、運動神(shen)經元(yuan)和海馬神(shen)經元(yuan)。此外,與EGF/bFGF聯用,可誘導神(shen)經干細(xi)(xi)(xi)胞向神(shen)經元(yuan)或膠質(zhi)細(xi)(xi)(xi)胞分(fen)化。該公(gong)司(si)生產的(de)CNTF表達系(xi)統為E.coli,純度≥95%,通過SDS-PAGE測定,內毒素(su)通過LAL方(fang)法測定≤10EU/mg。使用TF-1細(xi)(xi)(xi)胞的(de)細(xi)(xi)(xi)胞增(zeng)殖(zhi)實驗測定測量(liang)CNTF的(de)生物活性,ED50<100pg/ml。免疫(yi)細(xi)(xi)(xi)胞培養蛋白(bai)廠家注重客戶反(fan)饋,持續改進產品(pin)性能。廣(guang)東細(xi)(xi)(xi)胞肉細(xi)(xi)(xi)胞培養蛋白(bai)成(cheng)分(fen)有哪些

Wnt-3a(Wingless-type MMTV integration site family,member3A)是Wnt蛋(dan)(dan)白家族(zu)中(zhong)的(de)(de)一種(zhong)重要(yao)分(fen)(fen)泌型(xing)糖蛋(dan)(dan)白。Wnt-3a分(fen)(fen)泌后與細(xi)胞(bao)外基質(zhi)或載體蛋(dan)(dan)白結合,形成濃度(du)(du)梯度(du)(du),調控(kong)(kong)局(ju)部(bu)信號傳遞。Wnt-3a通過(guo)(guo)激活(huo)Wnt/β-catenin經(jing)典(dian)通路(lu)調控(kong)(kong)細(xi)胞(bao)行為,促進增殖并(bing)抑(yi)制自發分(fen)(fen)化(hua),維持(chi)干細(xi)胞(bao)干性(xing)(xing);而在某(mou)些特定濃度(du)(du)下,Wnt-3a可驅動神經(jing)前(qian)體細(xi)胞(bao)向特定神經(jing)元亞型(xing)分(fen)(fen)化(hua)。北京科昕生物科技(ji)有限公(gong)司(si)的(de)(de)Wnt-3a成分(fen)(fen)符合GMP級別(bie)要(yao)求,該產(chan)品(pin)表達系(xi)統為CHO,純(chun)度(du)(du)≥95%,通過(guo)(guo)SDS-PAGE測定。內毒(du)素(su)≤1EU/mg,通過(guo)(guo)LAL方法測定。通過(guo)(guo)Wnt-3a在CHO-K1細(xi)胞(bao)中(zhong)誘導Topflash報告基因活(huo)性(xing)(xing)的(de)(de)能(neng)力測量其生物活(huo)性(xing)(xing),該效應的(de)(de)ED50<30ng/mL。公(gong)司(si)依托嚴格的(de)(de)成分(fen)(fen)檢測與質(zhi)控(kong)(kong)體系(xi),可為企業提供(gong)成分(fen)(fen)說明(ming),協助企業選(xuan)擇合適的(de)(de)產(chan)品(pin)。天(tian)津BMP技(ji)術原(yuan)理IL-10的(de)(de)批(pi)量采(cai)購需要(yao)確保產(chan)品(pin)的(de)(de)純(chun)度(du)(du)、活(huo)性(xing)(xing)等(deng)特性(xing)(xing),從(cong)而確保產(chan)品(pin)應用的(de)(de)穩定性(xing)(xing)。

企業在(zai)研(yan)發(fa)環(huan)節對其提出的(de)需(xu)求往往各(ge)不相(xiang)同(tong),定(ding)制(zhi)(zhi)化研(yan)發(fa)能(neng)(neng)夠圍繞這些差異化目標展開,幫助企業獲得滿足(zu)特(te)定(ding)應用(yong)的(de)因(yin)子(zi)。G-CSF(粒細(xi)(xi)胞(bao)(bao)集落刺激因(yin)子(zi))屬于集落刺激因(yin)子(zi)家族,為單鏈糖蛋白,分子(zi)量約19-22kDa,是一(yi)類重(zhong)要(yao)(yao)的(de)造血(xue)因(yin)子(zi),在(zai)細(xi)(xi)胞(bao)(bao)培(pei)養中(zhong)(zhong)主要(yao)(yao)通(tong)過特(te)異性(xing)(xing)(xing)作用(yong)于髓(sui)系造血(xue)細(xi)(xi)胞(bao)(bao)(尤其是中(zhong)(zhong)性(xing)(xing)(xing)粒細(xi)(xi)胞(bao)(bao)譜系)調控(kong)其增殖(zhi)、分化和功(gong)能(neng)(neng)。它通(tong)過激活(huo)G-CSF受體(ti)(G-CSFR/CD114),觸發(fa)JAK-STAT3、PI3K/Akt和MAPK信號(hao)通(tong)路,促進中(zhong)(zhong)性(xing)(xing)(xing)粒細(xi)(xi)胞(bao)(bao)前體(ti)細(xi)(xi)胞(bao)(bao)的(de)增殖(zhi)與(yu)分化;此外,G-CSF有增強成熟中(zhong)(zhong)性(xing)(xing)(xing)粒細(xi)(xi)胞(bao)(bao)的(de)功(gong)能(neng)(neng),可以抑制(zhi)(zhi)中(zhong)(zhong)性(xing)(xing)(xing)粒細(xi)(xi)胞(bao)(bao)自發(fa)凋亡,并調節炎癥反(fan)應。北京科昕生物科技有限公司(si)生產(chan)的(de)G-CSF表達(da)系統(tong)為CHO,純度(du)≥95%,通(tong)過SDS-PAGE測定(ding)。內毒素≤10EU/mg,通(tong)過LAL方法(fa)測定(ding)。G-CSF的(de)生物活(huo)性(xing)(xing)(xing)通(tong)過誘導小鼠NFS-60細(xi)(xi)胞(bao)(bao)產(chan)生劑量依賴性(xing)(xing)(xing)增殖(zhi)反(fan)應確定(ding),ED50<0.5ng/mL,對應比活(huo)性(xing)(xing)(xing)≥1×107units/mg。該(gai)公司(si)能(neng)(neng)夠在(zai)定(ding)制(zhi)(zhi)化開發(fa)過程中(zhong)(zhong),滿足(zu)不同(tong)企業的(de)研(yan)發(fa)節奏與(yu)應用(yong)需(xu)求。
IL-23的(de)(de)價格(ge)受(shou)多種(zhong)因素(su)(su)(su)影響(xiang),包(bao)括表達系(xi)統、純度等(deng)級、包(bao)裝規(gui)格(ge)、訂購(gou)數量、定(ding)制(zhi)化(hua)程度與(yu)市(shi)場供(gong)需等(deng)。IL-23(白細(xi)(xi)(xi)胞(bao)(bao)介素(su)(su)(su)-23)是(shi)一種(zhong)異源(yuan)二聚(ju)體細(xi)(xi)(xi)胞(bao)(bao)因子(zi),屬于(yu)IL-12細(xi)(xi)(xi)胞(bao)(bao)因子(zi)家族(zu),IL-23由兩個亞基(ji)通(tong)過二硫鍵(jian)共價連接形成,IL-23通(tong)過結合(he)細(xi)(xi)(xi)胞(bao)(bao)表面(mian)的(de)(de)IL-23受(shou)體(IL-23R)發揮(hui)作用(yong)。IL-23主要由樹突細(xi)(xi)(xi)胞(bao)(bao)、巨(ju)噬細(xi)(xi)(xi)胞(bao)(bao)、單核細(xi)(xi)(xi)胞(bao)(bao)等(deng)抗原呈遞細(xi)(xi)(xi)胞(bao)(bao)分(fen)(fen)泌,在體外(wai)培養中促進(jin)Th17細(xi)(xi)(xi)胞(bao)(bao)分(fen)(fen)化(hua)與(yu)維(wei)持,IL-23與(yu)TGF-β、IL-6等(deng)細(xi)(xi)(xi)胞(bao)(bao)因子(zi)協同作用(yong),誘導初始(shi)CD4+T細(xi)(xi)(xi)胞(bao)(bao)分(fen)(fen)化(hua)為(wei)(wei)Th17細(xi)(xi)(xi)胞(bao)(bao);此外(wai)。IL-23可調節免疫應(ying)答,激活固有(you)免疫細(xi)(xi)(xi)胞(bao)(bao)(如(ru)γδT細(xi)(xi)(xi)胞(bao)(bao)、固有(you)淋巴細(xi)(xi)(xi)胞(bao)(bao)ILC3),增強其(qi)產生(sheng)(sheng)IL-17和IL-22的(de)(de)能(neng)力。因此,企業在采購(gou)時需要進(jin)行綜(zong)合(he)考量。北京科昕生(sheng)(sheng)物科技有(you)限公司(si)生(sheng)(sheng)產的(de)(de)IL-23表達系(xi)統為(wei)(wei)CHO,純度≥95%,通(tong)過SDS-PAGE測定(ding)。內毒素(su)(su)(su)通(tong)過LAL方(fang)法(fa)測定(ding)≤10EU/mg。IL-23的(de)(de)生(sheng)(sheng)物活性(xing)通(tong)過其(qi)誘導人(ren)自然殺傷淋巴瘤NK-92細(xi)(xi)(xi)胞(bao)(bao)分(fen)(fen)泌干擾素(su)(su)(su)γ的(de)(de)能(neng)力來(lai)測量,該(gai)效應(ying)的(de)(de)ED50<0.5μg/mL。該(gai)公司(si)通(tong)過優化(hua)生(sheng)(sheng)產工藝(yi)與(yu)供(gong)應(ying)鏈(lian)管理,為(wei)(wei)客戶提供(gong)高性(xing)價比選(xuan)擇。類(lei)器官(guan)細(xi)(xi)(xi)胞(bao)(bao)培養蛋白的(de)(de)參數規(gui)格(ge)是(shi)選(xuan)擇產品的(de)(de)重(zhong)要依據(ju),了解規(gui)格(ge)有(you)助于(yu)匹配企業需求。

BMP-7(骨(gu)形態發生(sheng)蛋(dan)(dan)白(bai)(bai)7)是細(xi)胞因(yin)(yin)子BMP家(jia)族的(de)同型二聚體成員,屬于轉化(hua)生(sheng)長因(yin)(yin)子β超家(jia)族。BMP-7是一種(zhong)高度保(bao)(bao)守(shou)的(de)蛋(dan)(dan)白(bai)(bai)序列,可能在(zai)細(xi)胞外基(ji)質中以與(yu)原纖維蛋(dan)(dan)白(bai)(bai)結合的(de)形式儲存(cun),調節發育過程中的(de)多(duo)種(zhong)生(sheng)物(wu)學(xue)(xue)信號,在(zai)多(duo)種(zhong)生(sheng)物(wu)學(xue)(xue)過程中發揮重要作用(yong),包括(kuo)參(can)與(yu)血管(guan)前體細(xi)胞的(de)血管(guan)形成,調節血管(guan)細(xi)胞群的(de)生(sheng)長、分(fen)化(hua)和(he)更新。當它與(yu)細(xi)胞膜上的(de)受體結合時,其下游(you)信號會拮抗TGF-β信號。此外,BMP-7具有多(duo)效作用(yong),包括(kuo)抗炎(yan)和(he)抗凋亡作用(yong)。北京(jing)科(ke)昕生(sheng)物(wu)科(ke)技有限公司生(sheng)產(chan)(chan)的(de)BMP-7表達系統(tong)為(wei)(wei)CHO,純度≥95%,通(tong)過SDS-PAGE測定,內(nei)毒素通(tong)過LAL方法測定≤10EU/mg。該產(chan)(chan)品(pin)通(tong)過ATDC-5軟(ruan)骨(gu)細(xi)胞的(de)堿性磷(lin)酸酶(mei)產(chan)(chan)量(liang)(liang)測量(liang)(liang)生(sheng)物(wu)活性,該效應的(de)預期ED50為(wei)(wei)0.02-0.04μg/ml。該公司依(yi)托南通(tong)GMP生(sheng)產(chan)(chan)基(ji)地,能保(bao)(bao)障批量(liang)(liang)供應的(de)產(chan)(chan)品(pin)質量(liang)(liang)符合GMP級別要求(qiu),滿足企業對BMP-7批量(liang)(liang)采(cai)購的(de)需求(qiu)。保(bao)(bao)持(chi)PDGF-BB活性需嚴格(ge)遵循儲存(cun)要求(qiu),避(bi)免(mian)反復凍融與(yu)不良環境影響。福(fu)建免(mian)疫細(xi)胞培養蛋(dan)(dan)白(bai)(bai)怎么保(bao)(bao)存(cun)
TGF-β1可抑制大(da)多數(shu)上皮(pi)細(xi)胞、內(nei)皮(pi)細(xi)胞和造(zao)血細(xi)胞的生長,使其(qi)停滯在G1期(qi),從而(er)調控細(xi)胞周期(qi)。廣東細(xi)胞肉細(xi)胞培(pei)養蛋白(bai)成分有哪(na)些
VEGF165(血(xue)(xue)管(guan)內(nei)皮(pi)生長因子165)是(shi)血(xue)(xue)管(guan)內(nei)皮(pi)生長因子(VEGF-A)的(de)主要(yao)亞型之一(yi),兩個單體通過(guo)二硫(liu)鍵連(lian)接,形成(cheng)(cheng)(cheng)功能性(xing)二聚(ju)體,在(zai)血(xue)(xue)管(guan)生成(cheng)(cheng)(cheng)和細(xi)(xi)胞(bao)(bao)(bao)培養(yang)中(zhong)(zhong)具有重要(yao)作用(yong)。通過(guo)激活VEGFR2/PI3K/AKT通路,抑制凋亡,常用(yong)于人(ren)臍(qi)靜(jing)脈內(nei)皮(pi)細(xi)(xi)胞(bao)(bao)(bao)(HUVECs)或微(wei)血(xue)(xue)管(guan)內(nei)皮(pi)細(xi)(xi)胞(bao)(bao)(bao)的(de)培養(yang),維持其(qi)增(zeng)殖(zhi)(zhi)能力。VEGF可誘(you)導血(xue)(xue)管(guan)形成(cheng)(cheng)(cheng),在(zai)Matrigel基質中(zhong)(zhong),VEGF165刺激內(nei)皮(pi)細(xi)(xi)胞(bao)(bao)(bao)形成(cheng)(cheng)(cheng)管(guan)狀結(jie)構,模擬血(xue)(xue)管(guan)生成(cheng)(cheng)(cheng);在(zai)干細(xi)(xi)胞(bao)(bao)(bao)分化中(zhong)(zhong),VEGF165可誘(you)導向內(nei)皮(pi)細(xi)(xi)胞(bao)(bao)(bao)或血(xue)(xue)管(guan)樣結(jie)構分化。北京科(ke)昕生物科(ke)技有限(xian)公司的(de)VEGF165培養(yang)工藝成(cheng)(cheng)(cheng)熟(shu),其(qi)采用(yong)無血(xue)(xue)清培養(yang)基與高密度培養(yang)技術(shu),結(jie)合完(wan)善質控,保障工藝穩定與產(chan)品(pin)質量。其(qi)生產(chan)的(de)VEGF165表達系統(tong)為CHO,純(chun)度≥95%,通過(guo)SDS-PAGE測定。內(nei)毒(du)素經過(guo)LAL方法測定含量≤10EU/mg。重組人(ren)VEGF165刺激HUVEC人(ren)類臍(qi)靜(jing)脈內(nei)皮(pi)細(xi)(xi)胞(bao)(bao)(bao)的(de)增(zeng)殖(zhi)(zhi)實驗顯示,該(gai)效(xiao)應的(de)ED50為0.2-10ng/mL。廣東細(xi)(xi)胞(bao)(bao)(bao)肉細(xi)(xi)胞(bao)(bao)(bao)培養(yang)蛋(dan)白成(cheng)(cheng)(cheng)分有哪些(xie)
北京(jing)科(ke)(ke)昕(xin)(xin)生(sheng)物科(ke)(ke)技(ji)有限(xian)(xian)公司在同(tong)(tong)行業(ye)領(ling)域(yu)中,一直處在一個不(bu)(bu)斷(duan)銳意(yi)進取(qu)(qu),不(bu)(bu)斷(duan)制造(zao)創(chuang)(chuang)新的(de)(de)市場(chang)高(gao)度,多年(nian)以來(lai)(lai)(lai)致力于發展(zhan)富有創(chuang)(chuang)新價(jia)值理(li)念的(de)(de)產品(pin)標(biao)準,在北京(jing)市等地區(qu)的(de)(de)化工(gong)中始終保持良好的(de)(de)商業(ye)**,成績(ji)讓我(wo)們(men)喜(xi)悅(yue),但不(bu)(bu)會讓我(wo)們(men)止步,殘酷的(de)(de)市場(chang)磨(mo)煉了我(wo)們(men)堅強不(bu)(bu)屈的(de)(de)意(yi)志(zhi),和諧溫馨的(de)(de)工(gong)作環境,富有營養的(de)(de)公司土壤滋(zi)養著我(wo)們(men)不(bu)(bu)斷(duan)開(kai)拓創(chuang)(chuang)新,勇(yong)于進取(qu)(qu)的(de)(de)無限(xian)(xian)潛力,北京(jing)科(ke)(ke)昕(xin)(xin)生(sheng)物科(ke)(ke)技(ji)供應攜手大家一起走(zou)(zou)向共同(tong)(tong)輝煌(huang)的(de)(de)未來(lai)(lai)(lai),回首過去,我(wo)們(men)不(bu)(bu)會因為取(qu)(qu)得了一點點成績(ji)而沾(zhan)沾(zhan)自(zi)喜(xi),相反的(de)(de)是面對(dui)競(jing)爭(zheng)越(yue)來(lai)(lai)(lai)越(yue)激烈的(de)(de)市場(chang)氛(fen)圍(wei),我(wo)們(men)更要明(ming)確自(zi)己(ji)的(de)(de)不(bu)(bu)足,做好迎接(jie)新挑戰的(de)(de)準備(bei),要不(bu)(bu)畏困難,激流(liu)勇(yong)進,以一個更嶄新的(de)(de)精神面貌迎接(jie)大家,共同(tong)(tong)走(zou)(zou)向輝煌(huang)回來(lai)(lai)(lai)!